← SynDRA
METHOCARBAMOL
SynDRA canonical compound SYN0023408 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CA1 |
|---|
| Mechanism of action | Muscle relaxant |
|---|
| Indication | muscle relaxant |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Muscle relaxant
- CA1 INHIBITOR
- Carbonic anhydrase I inhibitor
Drug classes
- Central Nervous System Agents
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Muscle Relaxant
ATC classes
- M03B · MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Cross-references
Synonyms
- glycerylguaiacolate carbamate
- guaiacol glyceryl ether carbamate
- guaiphenesin carbamate
- guaiamar carbamate
- Metocarbamol
- NSC-170960
- Delaxin
- Forbaxin
- Methocarbamol component of robaxisal
- Miolaxin
- Neuraxin
- Robaxin
- Robaxin-750
- Metocarbamolo
- Lumirelax
- Parabaxin
- Relestrid
- Myolaxene
- Miolaxene
- Metofenia
- Miorilas
- Surquetil
- Reflexyn
- Methocal
- Tresortil
- Romethocarb
- Etroflex
- Miowas
- Perilax
- Avetil
- Robinax
- Metofenina
- Guaiacol glyceryl ether carbamate
- Guaiphenesin carbamate
- Guaiphenesine carbamate
- Glycerylguaiacolate carbamate
- Glycerylguajacol-carbamat
- Methocarbamolum
Reported adverse events
- Bradycardia
- Anaphylactic reaction
- Amnesia
- Dyspepsia
- Hypersensitivity
- Leukopenia
- Urticaria
Look up METHOCARBAMOL in the interactive SynDRA portal →